ArticleVaccine2022
The correlates and dynamics of COVID-19 vaccine-specific hesitancy.
Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- How has co-design been used to address vaccine hesitancy globally? A systematic review.Human vaccines & immunotherapeutics · 2024Pooled it
- Quantifying vaccine dissemination for uptake comparisons between vaccines.Human vaccines & immunotherapeutics · 2026Article
- COVID-19 Vaccine Literacy Among Black Pregnant and Postpartum Women in the USA.Journal of racial and ethnic health disparities · 2026Article
- Acceptance and attitudes towards COVID-19 vaccination during pregnancy in Canada.Human vaccines & immunotherapeutics · 2025Article
- From institutional trust to digital literacy: Socioeconomic and political determinants of COVID-19 vaccine hesitancy among Czech adults based on a national panel survey.Human vaccines & immunotherapeutics · 2025Article
- Factors associated with COVID-19 vaccine brand preferences in the United States.Atlantic journal of communication · 2025Article
- Developing an intuitive decision support system for equitable vaccine distribution during pandemics.Scientific reports · 2025Article
- Faith in Crisis: An Exploratory Qualitative Study of the Role of Faith Community Leaders and Faith Community Nurses in Balancing Public Health Guidance and Spiritual Leadership During COVID-19 in the United States.Journal of religion and health · 2025Article
- Applying a diffusion of innovations framework to characterise diffusion groups and more effectively reach late adopters: a cross-sectional study on COVID-19 vaccinations in Canada in late 2021.BMJ public health · 2025Article
- COVID-19 Vaccination and Public Health: Addressing Global, Regional, and Within-Country Inequalities.Vaccines · 2024Review
- [Nurses' vaccination acceptance and related factors in the initial stage of COVID-19 vaccination in Korea: a cross-sectional study].Journal of Korean biological nursing science · 2024Article
- Article
- Institutional trust is a distinct construct related to vaccine hesitancy and refusal.BMC public health · 2023Article
- COVID-19 vaccination preferences during a pause in Johnson & Johnson vaccine administration.Vaccine: X · 2023Article
- COVID-19 Vaccine's Speed to Market and Vaccine Hesitancy: A Cross-Sectional Survey Study.Healthcare policy = Politiques de sante · 2023Article
- Article
- COVID-19 vaccine hesitancy and its drivers: An empirical study of the vaccine hesitant group in Malaysia.PloS one · 2023Article
- Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events.Epidemiology and health · 2023Article
- Navigating the uncertainty: A novel taxonomy of vaccine hesitancy in the context of COVID-19.PloS one · 2023Article
- An equitable vaccine delivery system: Lessons from the COVID-19 vaccine rollout in Canada.PloS one · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most work on COVID-19 vaccine hesitancy has focused on its attitudinal and demographic correlates among individuals, but the characteristics of vaccines themselves also appear to be important. People are more willing to take vaccines with higher reported levels of efficacy and safety. Has this dynamic sparked comparative hesitancy towards specific COVID-19 vaccines? We conduct a series of cross-sectional survey experiments to test for brand-based differences in perceived effectiveness, perceived safety, and vaccination intention. Examining more than 6,200 individuals in a series of cross-sectional surveys, we find considerably more reluctance to take the AstraZeneca and Johnson & Johnson vaccines compared to those from Pfizer and Moderna if offered, despite all vaccines being approved and deemed safe and effective by a federal regulator. Comparative hesitancy towards these vaccines grew over the course of fielding as controversy arose over their link to extremely rare, but serious side effects. Comparative vaccine-specific hesitancy is strongest among people who are usually most open to mass vaccination efforts. Its effects are substantial: most respondents reported a willingness to wait months for their preferred vaccine rather than receive either the AstraZeneca or Johnson & Johnson vaccine immediately. Our findings call for additional research on the determinants and consequences of COVID-19 vaccine-specific hesitancy and communication strategies to minimize this challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.